UKidney Sitemap

• Welcome
• Presentations
  • General Nephrology
    • Renal Disease and Protease Inhibitors in Aging HIV Patients
    • Molecular Mimicry
    • A patient with diabetes, hepatitis C and nephrotic syndrome
    • A female with diabetes and sudden onset of nephritic syndrome
    • A female with thrombocytopenia and thrombotic Microangiography
    • Prevention of progression of IgA nephropathy - the paediatric perspective
    • Prevention of renal disease in Spina Bifida
    • Prevention of renal disease in pregnant women with lupus
    • Is there a role for endothelin blockade in diabetic nephropathy?
    • Is diabetic nephropathy more than one disease?
    • New innovations in Gout: Febuxostat
    • Continuous Renal Replacement Therapy
    • Diet and Kidney Stone Prevention
    • Amphotericin B Nephrotoxicity
    • Sickle Cell Anemia and Renal Disease
    • Aggressive RAAS blockade should we change practice
    • IDNT and IRMA II Trials and Proteinuria Reduction
    • Proteinuria reduction with ARBs: The DROP Study
    • Supramaximal Dose of Candesartan in Proteinuric Renal Disease
    • Sleep Disorders in Patients with Chronic Kidney Disease
    • Coping with the Difficult Patient
    • Paraproteinemias (myeloma - amyloidosis)
    • HIV-Associated Kidney Disease
    • Hepatitis C Glomerulonephritis
    • Prevention of Focal Segmental Glomerulosclerosis
    • Prevention of IgA Nephropathy
    • Prenatal determinants for maximum nephron endowment at birth
    • Managing elderly persons with CKD stages 3-4
    • Renal Sparing Strategies in Renal Cell Carcinoma
    • Dual RAAS Blockade: Rationale and Literature Overview
    • Pitfalls in estimating renal failure in the elderly by eGFR
    • The role of Vitamin D for the prevention of diabetes mellitus and diabetic nephropathy
    • Vexing Cases in Lupus Nephritis
    • Very old persons with chronic kidney disease: is Dialysis harmful?
    • Prevention of nephrotoxicity of the chemotherapeutic agent
    • Syphilis and renal disease
    • Cardiorenal axis: Preventing and Treating diabetic nephropathy
    • Acid Base Physiology Update CSN Review Course 2009
    • Pregnancy in hemodialysis patients
    • Hypertension 2009
    • Nephrogenic systemic sclerosis: Update 2009
    • Microalbuminuria testing
    • Combining medications in the management of hypertension
    • Tubulointerstitial nephritis and uveitis (TINU): Case discussion
    • Wegener's granulomatosis
    • Hepatitis C and renal disease
    • Vaptans: Possible treatment for hyponatremia
    • Pulmonary renal syndromes in the ICU
    • Lithium induced diabetes insipidus
    • Lupus Nephritis
    • Highly active anti-retroviral therapy complications: a Nephrology Perspective
    • Surgical management of kidney stones
    • Electrolyte management in the Elderly
    • Hypertension and Angiotensin receptor blockers
    • Renal artery stenting: Indications and end-points
    • Renin angiotensin system
    • Chinese herb nephropathy
    • Renal sarcoidosis
    • Regulation of sodium excretion (Part 1)
    • Edema states and diuretics
    • Kidney stone prevention
    • Nephrogenic fibrosing dermopathy
    • Renal cell carcinoma
    • Hypertension in pregnancy
    • Renal pathology
    • Pulmonary-renal syndrome
    • Vasculitis and RPGN
    • Dialysis for Poisonings
    • eGFR and Microalbuminuria
  • Hypertension
    • CHEP 2011 Hypertension Recommendations
    • CHEP 2011 Guidelines for Hypertension: Treatment
    • Hypertension 2010: Principles of Management
    • Can BP control prevent renal damage?
    • Hypertension Management in Type 2 Diabetes
    • Reducing Cardiovascular Disease and Renal Disease by Treating Proteinuria
    • CHEP 2010 Guidelines for Hypertension: Treatment
    • Hypertension 2009-Beyond the Cuff-Calgary CME
    • Olmesartan: Slide library
    • Olmesartan: Exploring a new antihypertensive
    • Evaluation of Rasilez (aliskiren) with epilogue on ONTARGET trial
    • Current Trends and Controversies in the Diagnosis and Treatment of Hypertension
    • Hypertension management with focus on direct renin inhibitors
    • RADAR III: Hypertension and CKD
    • RADAR III: Microalbuminuria and CV disease
    • RADAR III: BP management and diabetic nephropathy
    • RADAR III: Severe Hypertension
    • RADAR III: Promoting treatment adherance
    • RADAR III: Lifestyle management
    • RADAR III: BP measurement
    • Focus on Stroke
    • Hypertension management: New in 2008
    • Treating hypertension
    • Assessing patients with hypertension
    • CHEP 2009 Guidelines for hypertension: Diagnosis
  • Hemodialysis
    • Physical Examination of Arteriovenous Fistula
    • Atlas of Dialysis Vascular Access
    • Existential psychotherapy in end of life care
    • Withholding or withdrawing dialysis
    • Pregnancy in women on dialysis
    • Conservative management vs. dialysis in the elderly patient with stage 5 CKD
    • Prevention of Intradialytic Hypotension
    • Hemodialysis access emergencies
    • Acute complications of hemodialysis
    • Home and nocturnal hemodialysis
    • Blood volume monitoring and sodium profiling in HD
    • Past, present, future of hemodialysis
    • Non-infectious complications of HD catheters
    • Hemodialysis adequacy
    • Dialyzers and dialysis machines
    • Urea kinetics
  • Peritoneal Dialysis
    • Peritoneal Dialysis Grand Rounds
    • Encapsulating Sclerosing Peritonitis: Radiological perspective
    • Diagnosis of Encapsulating Sclerosing Peritonitis
    • The Importance of Residual Kidney Function For Patients on Dialysis
    • The Physiology of Peritoneal Dialysis
    • Non-infectious complications of Peritoneal Dialysis
    • Peritoneal Dialysis Adequacy
    • The Embedded Peritoneal Dialysis Catheter
    • Blind bedside insertion of PD Catheters
    • Interventional Radiology and Peritoneal Dialysis
    • Introduction to PD Catheter Insertion Methods
    • Peritoneoscopic Insertion of a Peritoneal Dialysis Catheter
    • The Importance of Residual Kidney Function For Patients on Dialysis, Dr. Jeffrey Perl
    • Prevention of Peritoneal Dialysis-related infections
    • Controversy of biocompatible solutions in peritoneal dialysis
    • Growth of Peritoneal dialysis: Impact of home assistance
    • Update in Peritoneal Dialysis CSN Review Course 2009
    • Peritoneal dialysis: Video Preceptorship
    • Past, Present, Future of Peritoneal Dialysis
    • Adequacy of Peritoneal Dialysis
    • Overview and physiology of peritoneal dialysis
    • Challenging cases in peritoneal dialysis
    • Peritoneal dialysis in the elderly
    • PD in acute renal failure
    • Infectious complications of PD
    • Noninfectious complications of PD
    • Preservation of renal function
    • Ultrafiltration failure in PD
    • Primer of peritoneal dialysis
  • Chronic Kidney Disease
    • Chronic Kidney Disease and Osteoporosis: How to Diagnose and Treat
    • Kidney Health - Spreading the Word
    • Beta Blockers in Chronic Kidney Disease
    • Psychological concepts in sexuality in patients with renal disease
    • Prevention of long-term sequelae of pre-eclampsia
    • Sexual function and quality of life in patients with CKD
    • Haemoglobin: A moving target in CKD Patients
    • The relevance of the attachment system for adapting to chronic illness
    • The Impact of Phosphate Food Additives in Chronic Kidney Disease
    • Bone and Mineral Metabolism and Disease in CKD
    • Chronic Kidney Disease: Overview
    • Renal anemia
    • Cardiovascular complications of chronic kidney disease
    • Renal Anatomy and Physiology: a foundation for learning about chronic renal failure
    • EMiNEM: Education in Mineral Metabolism
    • A Trial of Care for CKD: Can-Prevent
    • Sudden Death in Chronic Kidney Disease
    • Prevention of Chronic Kidney Disease in patients with disorders of the complement system
    • Pulmonary hypertension in end-stage renal disease
    • Detection, monitoring and referral of chronic kidney disease
    • Biology of uremia: Vascular disease
    • Sensipar
  • Renal Transplantation
    • Statins and RAS blockade in prevention of kidney disease in kidney transplantation
    • Living donor assessment and long-term complications
    • Prevention of nephrotoxicity of immunosuppressive agents in kidney transplantation
    • Essential clinical issues in renal transplantation
    • Commercial transplantation
    • BK Polyoma virus infection in renal transplantation
    • Hepatitis B in renal transplant recipients
    • Tissue typing and cross-matching in kidney transplantation
    • Immunosuppressive Medications
    • Kidney Pancreas Transplantation
    • Overview of renal transplantation
    • Essentials of live kidney donation
    • Viral infections in renal transplantation
    • Transplant emergencies
    • Hypertension after renal transplant
    • Fungal infections in transplantation
    • Renal transplant surgery
  • Bone and Mineral Metabolism
    • Renal Osteodystrophy: What's New
    • Vascular calcification symposium 2009
    • Introduction to the KDIGO Guidelines
    • Fosrenol: An overview of a new phosphorus binder
    • Biology of uremia: Calcium, Phosphate and Vitamin D
    • Vascular calcification symposium 2008
    • Vascular calcification in CKD
    • Hyperparathyroidism - Focus on calcium
    • Overview of bone and minreal metabolism
    • Vitamin D in chronic kidney disease
  • Prevention in Renal Disease Conference 2011
    • Update in Pancreas Transplantation
    • Sex hormones and progression of CKD
    • Proteinuria and cardiovascular disease
    • Overcoming barriers to end-of-life decision making
    • Latest Developments in Bone Mineral Metabolism
    • Prevention of AKI in the elderly
    • Diabetic nephropathy - primary prevention and regression
    • Prevention of RRF loss in dialysis patients
    • Prevention of peritonitis in patients on PD
    • Prevention of non immunologically mediated chronic kidney allograft injury
    • Prevention of late immunologically mediated chronic kidney allograft injury
    • Transition of Pediatric Patients to Adult Nephrology: Views of an adult Nephrologist
    • Transition of Pediatric Renal Transplant Patients to Adult Nephrology
    • Rare pediatric diagnoses now surviving into adulthood
    • Transition of Pediatric Patients to Adult Nephrology
    • The Importance of Vitamin D
    • The role of hyperuricemia in CKD
    • Membranous nephropathy
    • A Decade of Progress in Lupus Nephritis
    • Prevention of sudden death in the dialysis patient
    • Rational approach to vascular access in the elderly
  • Peritoneal Dialysis Grand Rounds 2011
    • PD Catheter Types and Clinical Outcomes
    • Indications for PD Catheter Removal
    • Access Complications: PD vs. HD
    • PD Catheter Insertion: The Nephrologist's Perspective
    • PD Catheter Insertion: The Radiologist's Perspective
    • Approach to Malfunctioning PD Catheters
    • PD Catheter Insertion: The Surgeon's Perspective
    • PD Catheter Insertion Techniques
    • Buried PD Catheters
    • Post-Implantation Management of PD Catheters
    • PD Access Triage and the Role of a PD Access Coordinator
• Forum
  • Welcome to UKidney Forums
    • Rules
  • Renal Physicians and Allied Health Forums
    • Nephrology trainees and fellows
    • Nephrology Nurses and NPs
      • Nephrology Nurse Educators
    • Nephrology technologists
    • Nephrology pharmacists
    • Nephrologists
      • By Region
        • North America
          • Canada
            • GTA Journal Club
          • United States
        • Europe
        • South America
        • Middle East
        • Australia
        • Australia
        • Asia
      • Upcoming meetings
      • Clinical Trials
      • Bone and Mineral Metabolism Forum
      • Conference Room
      • Private Conference Room
    • Nephrology dieticians
    • UKidney self-assessment Quiz Discussion
  • Patient forums
    • Ask the Experts
      • Read Me First Please
      • Hypertension
      • Kidney Stones
      • Hemodialysis
        • Home Hemodialysis
      • Peritoneal dialysis
      • Kidney Transplant
      • Anemia
      • Kidney Disease (General)
    • General discussion
  • General discussion
• Blog
  • Latest Post
    • Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
    • No benefit of Aliskiren added on to ACE or ARB: a disappointing development
    • Generic drugs: a dangerous public misunderstanding?
    • Novel Tools to Teach Nephrology
    • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
    • Olmesartan delays the onset of microalbuminuria, but more deaths seen
    • Growing new kidneys? An idea whose time may have come
    • Chloroquine in Lupus: Prevents flares and saves lives
    • Is rosuvastatin (Crestor) nephrotoxic?
    • Ezetimibe and Simvastatin in Chronic Kidney Disease: Good News
    • Class Review of Phosphate Binders
    • Blood pressure targets called in to question? Yes and No
    • Benlysta: Promising new Lupus drug on the horizon
    • Important genetic link found for FSGS in African Americans
    • Sirolimus and Everolimus in Polycystic Kidney Disease
    • Angiotensin Receptor Blockers and Cancer
    • Vitamins are harmful in patients with chronic kidney disease
    • Thiazide diuretics are not created equal, especially with the new ARB azilsartan
    • Transplant Drug Two-Year Study Outcomes Show Superior Kidney Function
    • The ACCORD Blood Pressure Study: The J-point realized?
  • Categories
    • General nephrology
      • Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
      • Generic drugs: a dangerous public misunderstanding?
      • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
      • Dilemma for Dialysis Patients, Skinny is Dangerous
      • Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
    • Hemodialysis
      • In-center nocturnal hemodialysis: a novel therapy
    • Hypertension
      • No benefit of Aliskiren added on to ACE or ARB: a disappointing development
      • Olmesartan delays the onset of microalbuminuria, but more deaths seen
      • Growing new kidneys? An idea whose time may have come
      • Chloroquine in Lupus: Prevents flares and saves lives
      • Is rosuvastatin (Crestor) nephrotoxic?
    • Kidney transplantation
      • RecycleMe: An innovative website promoting organ donation
      • Major breakthrough in transplantation immunity
    • Nephrology Education
      • Novel Tools to Teach Nephrology
    • UKidney information
      • UKidney Blog
    • Uncategorized
  • Tags
    • UKidney information
      • UKidney Blog
    • clinical trials
      • Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
      • No benefit of Aliskiren added on to ACE or ARB: a disappointing development
      • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
      • Chloroquine in Lupus: Prevents flares and saves lives
      • Is rosuvastatin (Crestor) nephrotoxic?
    • hemodialysis
      • Dilemma for Dialysis Patients, Skinny is Dangerous
      • In-center nocturnal hemodialysis: a novel therapy
      • Statins in end-stage renal failure: failure revisted
    • diabetic nephropathy
      • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
      • Olmesartan delays the onset of microalbuminuria, but more deaths seen
      • ACE and ARB in combination: Still a viable option?
    • chronic kidney disease
      • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
      • Growing new kidneys? An idea whose time may have come
      • Is rosuvastatin (Crestor) nephrotoxic?
      • Ezetimibe and Simvastatin in Chronic Kidney Disease: Good News
      • Class Review of Phosphate Binders
    • general nephrology
      • Novel Tools to Teach Nephrology
      • More evidence for mycophenolate mofetil in lupus nephritis
      • ACE and ARB in combination: Still a viable option?
    • hypertension
      • No benefit of Aliskiren added on to ACE or ARB: a disappointing development
      • Olmesartan delays the onset of microalbuminuria, but more deaths seen
      • Blood pressure targets called in to question? Yes and No
      • Angiotensin Receptor Blockers and Cancer
      • Thiazide diuretics are not created equal, especially with the new ARB azilsartan
    • diagnostic technology
      • eGFR and microalbuminuria: a powerful duo
    • kidney transplantation
      • Removing a failed kidney allograft improves survival?
      • RecycleMe: An innovative website promoting organ donation
      • Major breakthrough in transplantation immunity
    • lupus nephritis
      • Chloroquine in Lupus: Prevents flares and saves lives
      • More evidence for mycophenolate mofetil in lupus nephritis
  • Bloggers
    • Dave Racinsky
    • Dr. Jordan Weinstein
      • Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
      • No benefit of Aliskiren added on to ACE or ARB: a disappointing development
      • Generic drugs: a dangerous public misunderstanding?
      • Bardoxolone in Chronic Kidney Disease: A major breakthrough?
      • Olmesartan delays the onset of microalbuminuria, but more deaths seen
    • Kenar Jhaveri
      • Novel Tools to Teach Nephrology
    • Moumita Barua
      • Important genetic link found for FSGS in African Americans
    • Nikhil Shah
    • Roger Smith
    • Tom Cruise
  • TeamBlog
• YouTubule
  • Pathology Videos
    • Histopathology Kidney - Membranous glomerulonephritis
    • Histopathology Kidney - Acute tubular necrosis
    • Histopathology Kidney - Acute transplant rejection
    • Histopathology Kidney - Diabetic glomerulosclerosis
    • Histopathology Kidney - Septic infarct
    • Histopathology Kidney - Renal cell carcinoma
    • Histopathology Kidney - Transitional cell carcinoma
    • Histopathology Kidney - Wilms tumor
    • Histopathology Kidney - Acute and chronic pyelonephritis
    • Histopathology Kidney - Adult polycystic disease
    • Histopathology Kidney - Arteriolosclerosis (hypertension)
    • Histopathology Kidney - Interstitial nephritis
    • Histopathology Kidney - Rapidly progressive glomerulonephritis
    • Histopathology Kidney - Acute tubular necrosis from ethylene
    • Histopathology Kidney - Systemic lupus erythematosus
  • General Nephrology Videos
    • Webcast - ISN 50 Years Panel Discussion
  • Hypertension Videos
  • Peritoneal Dialysis Videos
    • Peritoneal Dialysis Catheter Insertion at the Bedside
    • Video: Introduction to PD
    • Video: Percutaneous insertion of PD catheter
    • Video: Step-by-step Guide
      • Part 2
      • Part 3
      • Part 4
  • Hemodialysis Videos
    • Video: Dialysis modality choices
  • Renal Transplant Videos
  • Chronic Kidney Disease Videos
    • Chronic kidney disease video part 1 - French
    • Chronic kidney disease video part 1 - English
    • Video: Overview of hyperparathyroidism
    • Chronic kidney disease video part 2 - English
    • Chronic kidney disease video part 3 - English
    • Chronic kidney disease video part 2 - French
    • Chronic kidney disease video part 3 - French
    • Video: Sensipar for SHPT
• Resources
  • Nutrition
  • Nephrology Tools
    • Blood pressure log
    • eGFR Calculator
    • Bone & Mineral Metabolism Resource
  • Nephrology Self Assessment Quiz
  • Ask the Experts
    • Index
      • Can I use topical NSAID cremes or marijuana creams?
      • Urinary NGAL and acute renal failure
      • Would you biopsy him?
      • Salt restriction and 24 hour urine sodium
      • What is the difference between different types of angiotensin receptor blockers?
      • Diets contradict for Kidney failure with type 2 Diabetes
      • Where do you use ACE inhibitors versus ARBs in treating hypertension
      • Are there any major changes expected in the CHEP 2012 guidelines?
      • What is microalbuminuria?
      • Nephrotic syndrome in a patient with recent malignancy
    • Categories
      • For Patients
        • Can I use topical NSAID cremes or marijuana creams?
        • Diets contradict for Kidney failure with type 2 Diabetes
      • For Professionals
      • General Nephrology Questions
        • Urinary NGAL and acute renal failure
        • Would you biopsy him?
        • Salt restriction and 24 hour urine sodium
        • What is microalbuminuria?
      • Hypertension Questions
        • What is the difference between different types of angiotensin receptor blockers?
        • Where do you use ACE inhibitors versus ARBs in treating hypertension
        • Are there any major changes expected in the CHEP 2012 guidelines?
      • Unfiled Questions
        • Nephrotic syndrome in a patient with recent malignancy
    • Tags
      • General
      • Sharing
      • Info
      • Discussions
      • Thank You
      • Congratulations
      • Membranous Glomerulonephritis
      • Microalbuminuria
      • Angiotensin receptor blockers
      • ARBs
• Publications
  • Nephrology Journals
  • Nephrology Books
    • Nephrology manuals
    • Electrolyte handbook
    • Nephrology Atlas
    • Dialysis of Drugs
    • Atlas of Dialysis Vascular Access
  • ISN News
• Guidelines
  • Access and adequacy
  • Anemia mangement
  • Bone metabolism
  • KDIGO Guidelines
  • Hypertension in CKD
  • Peritoneal Dialysis
• Network